These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 32410703

  • 1. Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study.
    Jeon J, Kim DH, Jang HR, Lee JE, Huh W, Kim HY, Kim DJ, Kim YG.
    BMC Nephrol; 2020 May 01; 21(1):180. PubMed ID: 32410703
    [Abstract] [Full Text] [Related]

  • 2. Potential role of urinary angiotensinogen in predicting antiproteinuric effects of angiotensin receptor blocker in non-diabetic chronic kidney disease patients: a preliminary report.
    Jang HR, Lee YJ, Kim SR, Kim SG, Jang EH, Lee JE, Huh W, Kim YG.
    Postgrad Med J; 2012 Apr 01; 88(1038):210-6. PubMed ID: 22357774
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
    Jang HR, Jeon J, Park JH, Lee JE, Huh W, Oh HY, Kim YG.
    Transl Res; 2014 Nov 01; 164(5):400-10. PubMed ID: 24929205
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
    Park JH, Jang HR, Lee JH, Lee JE, Huh W, Lee KB, Kwon YJ, Do JY, Kim HY, Kim YG.
    Nephrology (Carlton); 2015 Apr 01; 20(4):279-85. PubMed ID: 25522682
    [Abstract] [Full Text] [Related]

  • 5. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
    Yamamura-Miyazaki N, Michigami T, Satomura K, Urushihara M, Kagami S, Yamamoto K.
    Pediatr Nephrol; 2020 Jul 01; 35(7):1307-1314. PubMed ID: 32162100
    [Abstract] [Full Text] [Related]

  • 6. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC, Kim J, Cho A, Kim DH, Lee YK, Ryu H, Kim H, Oh KH, Oh YK, Hwang YH, Lee KB, Kim SW, Kim YH, Lee J, Ahn C, KNOW-CKD Investigators Group.
    J Korean Med Sci; 2020 Jun 08; 35(22):e165. PubMed ID: 32508065
    [Abstract] [Full Text] [Related]

  • 7. Urinary angiotensinogen level is correlated with proteinuria in renal transplant recipients.
    Erdogmus S, Sengul S, Kocak S, Kurultak I, Celebi ZK, Kutlay S, Keven K, Erbay B, Erturk S.
    Transplant Proc; 2013 Apr 08; 45(3):935-9. PubMed ID: 23622592
    [Abstract] [Full Text] [Related]

  • 8. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ, Kim SS, Kim IJ, Song SH, Kim EH, Seo JY, Kim JH, Kim S, Jeon YK, Kim BH, Kim YK.
    J Korean Med Sci; 2017 May 08; 32(5):782-788. PubMed ID: 28378551
    [Abstract] [Full Text] [Related]

  • 9. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
    Lee YJ, Cho S, Kim SR, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG.
    Postgrad Med J; 2011 Oct 08; 87(1032):664-9. PubMed ID: 21715572
    [Abstract] [Full Text] [Related]

  • 10. The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients.
    Jang HR, Kim SM, Lee YJ, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG.
    Ann Med; 2012 Aug 08; 44(5):448-57. PubMed ID: 21366514
    [Abstract] [Full Text] [Related]

  • 11. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
    Urushihara M, Nagai T, Kinoshita Y, Nishiyama S, Suga K, Ozaki N, Jamba A, Kondo S, Kobori H, Kagami S.
    Pediatr Nephrol; 2015 Jun 08; 30(6):975-82. PubMed ID: 25523477
    [Abstract] [Full Text] [Related]

  • 12. The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.
    Kutlugün AA, Altun B, Aktan U, Turkmen E, Altindal M, Yildirim T, Yilmaz R, Arici M, Erdem Y, Turgan C.
    Amyloid; 2012 Mar 08; 19(1):28-32. PubMed ID: 22320202
    [Abstract] [Full Text] [Related]

  • 13. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
    Lee YJ, Jang HR, Kim SG, Chae DW, Do JY, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG.
    Nephrology (Carlton); 2011 Jul 08; 16(5):502-10. PubMed ID: 21303424
    [Abstract] [Full Text] [Related]

  • 14. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z, Xu B, Xu C.
    Ir J Med Sci; 2015 Jun 08; 184(2):297-304. PubMed ID: 24664631
    [Abstract] [Full Text] [Related]

  • 15. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C, VIVALDI investigators.
    Nephrol Dial Transplant; 2008 Oct 08; 23(10):3174-83. PubMed ID: 18450829
    [Abstract] [Full Text] [Related]

  • 16. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC, Kang AY, Jang JY, Kim H, Han M, Oh KH, Kim SH, Noh JW, Cheong HI, Hwang YH, Ahn C.
    BMC Nephrol; 2015 Jun 20; 16():86. PubMed ID: 26092580
    [Abstract] [Full Text] [Related]

  • 17. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY, Ding XQ, Lv WL, Teng J, Zhong YH.
    Mol Biol Rep; 2013 Oct 20; 40(10):5817-24. PubMed ID: 24065527
    [Abstract] [Full Text] [Related]

  • 18. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
    Aybal Kutlugun A, Altun B, Buyukasik Y, Aki T, Turkmen E, Altindal M, Yildirim T, Yilmaz R, Turgan C.
    Transpl Int; 2012 Jan 20; 25(1):13-8. PubMed ID: 21923802
    [Abstract] [Full Text] [Related]

  • 19. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H, Alper AB, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG.
    Hypertension; 2009 Feb 20; 53(2):344-50. PubMed ID: 19075095
    [Abstract] [Full Text] [Related]

  • 20. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
    Kim YG, Song SB, Lee SH, Moon JY, Jeong KH, Lee TW, Ihm CG.
    Clin Exp Nephrol; 2011 Oct 20; 15(5):720-726. PubMed ID: 21695414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.